Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.470NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.31 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.51 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.122.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.40.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.196NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.117NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBLNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.466.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.1 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.46 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.99 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.528NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.91 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.617NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KC.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KL.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used